focus -WSS

focus

author：knowledge 2025-08-12 06:45:25 - browse：86895

Illumina building. -- biotech coverage from STAT — Adobe

LONDON — The European Union on Wednesday issued an antitrust fine of $475 million to the U.S. genetic sequencing giant Illumina for closing its acquisition of cancer detection company Grail before clearing it with regulators.

The fine amounts to nearly 10% of Illumina’s annual global revenue, which is the most the European Commission can penalize a company under its merger regulations. The commission called Illumina’s actions “an unprecedented and very serious infringement” of the EU’s policies, including the “cornerstone” that regulators review deals that can alter the market.

The commission also issued what it called a symbolic fine of 1,000 Euros, or about $1,100, to Grail for what it said was the firm’s “active role” in the deal’s infringement of EU rules.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Bright Health sells Medicare Advantage business to Molina
Next article： Option Care buys Amedisys in $3.6 billion home care deal

leisure time

WSS

What to expect at HLTH 2023, the health care industry conference

FDA authorizes Novavax’s updated Covid

4th of July breaks record for highest global temperature ever measured

When is a doctor not a doctor? Try when patients address women doctors

Colorectal cancer study finds potential in overlooked immune cell

FDA rejects Alnylam's heart disease treatment over insufficient data

hotspot

focus

Wikipedia

Bright Health sells Medicare Advantage business to Molina

Eli Lilly buys Point Biopharma in radiopharmaceuticals play

Affirmative action in medical school literally saved lives

AI can decode, harness the power of the humane immune system

At least 13 dead in Texas as scorching temps continue

Eli Lilly buys Point Biopharma in radiopharmaceuticals play

Indiana Supreme Court upholds abortion ban, says state constitution gives only limited protections

A virus, fished out of a lake, may have saved a man’s life

New air purifier tech could be key to improving indoor air quality

Readout Newsletter: Biotech news, including Moderna's Covid vaccine

knowledge

Listen: PBM conflicts, RSV vaccines, & the future of flu season

Chemotherapy drug shortage eases slightly but still widespread

FDA panel signals lack of confidence in Amgen cancer drug data

When women are denied an abortion, their children fare worse than peers

Chan Zuckerberg Biohub Chicago to focus on inflammation

Bill would stop addiction treatment from triggering child abuse inquiry

entertainment

leisure time

focus

focus